Neuromodulation Devices Market Report 2023 (Global Edition)

Global Neuromodulation Devices Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Neuromodulation Devices Industry growth. Neuromodulation Devices market has been segmented with the help of its Type, Application Technology, and others. Neuromodulation Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

Report scope is customizable as we have a huge database of Neuromodulation Devices industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

By Type, the Spinal Cord Stimulator SCS Systems segment has dominated the Neuromodulation Devices Market!

Based on the type spinal cord stimulator SCS systems has dominated the market as the number of chronic spinal cord diseases are growing. According to the World Health Organization, every year, around the world, between 250,000 and 500,000 people suffer a spinal cord injury (SCI).

• Deep Brain Stimulation DBS Systems
• Spinal Cord Stimulator SCS Systems
• Diaphragm Pacing System DPS
• Respiratory Electrical Stimulation RES
• Vagus Nerve Stimulation VNS
• Gastric Electrical Stimulation GES
• Transcranial Magnetic Stimulation TMS
• Transcutaneous Electrical Nerve Stimulation TENS

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Neuromodulation Devices Industry. Request a Free Sample PDF!

By Application, Parkinson’s disease segment dominated the Neuromodulation Devices Market!

Based on the application, Parkinson’s disease segment dominated the neuromodulation devices market owing to the rising prevalence of Parkinson’s disease. According to the Parkinson's Foundation, nearly 90,000 people in the U.S. are diagnosed with PD each year.

• Chronic Pain
• Parkinson's Disease
• Urine Incontinence
• Epilepsy
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Neuromodulation Devices market report 2023 Edition by contacting our team.

Neuromodulation Devices Technology Segment Analysis

Based on technology, the internal segment led the market with a high revenue share owing to a growth in the number of patients suffering from various forms of headaches, depression, and heart-related ailments.

• Internal
• External

Neuromodulation Devices End-use Segment Analysis

Based on end users, the hospitals & ambulatory surgery centers segment dominates the neuromodulation devices market as many people are preferring hospitals whether its neurological diseases or spinal cord-related diseases.

• Hospitals & Ambulatory Surgery Centers (ASC)
• Clinics & Physiotherapy Centers
• Others

The North America Neuromodulation Devices Market dominates the overall market:

Geographically, the global Neuromodulation devices market is divided into regions like North America, Europe, Asia Pacific, Latin America, and Middle-east Countries. North America dominates the neuromodulation devices market owing to the rising prevalence of Parkinson’s disease, substantial expenditure on research and development to produce innovative therapeutic solutions, number of patients with neurological disorders and spinal cord diseases.

Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

Neuromodulation Devices Industry News:

In August 2022, Abbott introduced Canada’s first remote neuromodulation patient-care technology. Abbott announced the Health Canada licensing of NeuroSphere virtual clinic, a remote programming technology that the company claims are the first of its kind in Canada and is compatible with Abbott’s suite of neuromodulation technologies. According to Abbott, this feature enables clinicians to prescribe new treatment settings remotely to the patient’s neurostimulation device using the clinician programmer app and a new, simple and secure remote care connection.

Top Companies Market Share in Neuromodulation Devices Industry: (In no particular order of Rank)

• Medtronic
• Boston Scientific Corporation
• St.Jude Medical
• Synapse Biomedical
• Nevro
• Neurosigma
• Neuropace
• Neuronetics
• Cyberonics
• BioControl Medical
• Confidential Data
• Access The Paid Version
• Data Hidden

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..